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The timely diagnosis of cancer is a frequent theme in the lay
press and an increasingly common topic for quality improvement
initiatives.1 2
The UK’s health secretary has advocated ranking general
practices on the NHS Choices website according to how
promptly patients subsequently diagnosed with cancer are
referred to specialist services for suspected cancer.3 But is such
a policy based on evidence? Its main assumption is that the
multiple visits made by these patients to primary care before
referral chiefly reflect poor professional performance rather
than factors such as clinical complexity, reasonable watchful
waiting, or the need for appropriate investigations in primary
care. We review the occurrence of multiple pre-referral
consultations and discuss how a better understanding of variation
between cancers might improve the timeliness of diagnosis.
How common aremultiple consultations?
Most patients with cancer present to primary care with
symptoms that have low or very low positive predictive values.
Even “red flag” symptoms (such as rectal bleeding, dysphagia,
haemoptysis, and haematuria) have positive predictive values
for cancer of <10% in men,4 and these values are typically up
to twofold lower for women and even lower for young adults
and children (<1%).5 This means that the great majority of
patients with such symptoms will not have cancer.
Despite the low specificity of cancer symptoms, about 80% of
patients subsequently diagnosed with cancer are referred to a
hospital specialist after one (50%) or two (30%) consultations.6 7
But a substantial minority (20%) of patients with cancer visit a
primary care doctor with relevant symptoms three or more times
before referral. This number is often considered by policy
makers and cancer charities to reflect an avoidable delay.8 9 In
this article we use the term “multiple consultations” to denote
three or more visits to primary care before referral.
Why multiple consultations matter
The number of consultations is associated with increased time
from presentation to referral for cancer. National audit data
show that the median time to referral is 34 days for patients
having three consultations, 47 days for four consultations, and
96 days for five or more consultations.6However, these interval
data are skewed to the right, meaning that many patients
experience notably longer times to referral—for example, a
quarter of patients with three, four, and five or more
consultations experience intervals longer than 64, 90, and 172
days, respectively.
Stage at diagnosis is a strong predictor of survival, so prolonging
the interval from presentation to diagnosis could increase the
risk of stage progression and poorer clinical outcomes.10 11
However, confounding by patients with rapidly progressive
disease who present with advanced cancer and have poor
outcomes despite prompt referral makes the interpretation of
observational studies challenging.12
Multiple consultations also adversely affect the experience of
care as patients with cancer and their relatives express strong
preferences for a prompt diagnosis.8 13 Not suspecting the
diagnosis of cancer, or failing to act on such a suspicion, can
also be upsetting for doctors.
Why do multiple consultations occur?
Considering different cancers separately is critical for gaining
insight into the challenges of diagnosis. Although often referred
Correspondence to: G Lyratzopoulos gl290@medschl.cam.ac.uk
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2014;349:g7400 doi: 10.1136/bmj.g7400 (Published 10 December 2014) Page 1 of 6
Analysis
ANALYSIS
to as a single entity, cancer is a highly heterogeneous disease,
arising from different organs and systems and associated with
diverse symptoms.
National audit and patient survey data show that the strongest
predictor of multiple consultations is tumour site. Between 30%
and 50% of patients subsequently diagnosed with multiple
myeloma or pancreatic, stomach, or lung cancer have multiple
consultations, compared with <10% of patients subsequently
diagnosed with breast cancer or melanoma (figure⇓).6 7 These
differences seem to reflect the “symptom signature” of different
cancers—cancers wheremost patients present with fairly specific
symptoms (such as a palpable breast lump or a visible skin
lesion) are less associated with multiple consultations than those
where most patients present with non-specific symptoms (such
as back or abdominal pain). The proportion of patients with a
given cancer who experience multiple consultations could
therefore be considered a marker of the difficulty of suspecting
that cancer at first presentation to primary care.
Another relevant factor is the need for initial investigations for
non-specific symptoms in primary care. This is good clinical
practice but often requires additional consultations to discuss
the results and to plan the next steps.14 In the English National
Audit of Cancer Diagnosis in Primary Care about 80% of
patients with multiple consultations had at least one diagnostic
test—twice the proportion of patients who were referred after
a single consultation.
Factors unrelated to the quality of clinical reasoning during the
consultation may also be implicated. A recent study of
significant event audits in the diagnosis of lung cancer revealed
several such factors, including poor communication between
primary and secondary care services and patient preference for
delayed referral.1
If poor medical practice were the main reason for multiple
consultations, theymight be expected only in patients consulting
a minority of clinicians. But given that up to 20% of all patients
with newly diagnosed cancer in England have multiple
consultations, it seems improbable that these thousands of
patients are seen by a few poorly performing GPs.
Considered together, these observations suggest that diagnostic
difficulty and the need for investigation of poorly differentiated
symptoms in primary care are more likely to be the drivers for
multiple consultations than poor diagnostic reasoning and
suboptimal professional practice.
Diagnostic difficulty
The association between cancer site and multiple consultations
led us to question whether individual cancers could be classified
by diagnostic difficulty. If so, this knowledge might help to
guide the development of tests and interventions for decision
support and quality improvement, providing a useful framework
to guide future practice, policy, and research.15 Using the
proportion of patients who have multiple consultations as a
measure of diagnostic difficulty, cancers can be divided into
those that are harder to suspect (>30% of patients), easier to
suspect (<10%), and those of intermediate diagnostic difficulty
(10-30%) (table⇓).
Harder to suspect cancers
Most patients with these cancers present with non-specific
symptoms that are often seen in primary care. For example, two
thirds of patients with multiple myeloma present with back
pain,16 and nearly half of patients with pancreatic cancer with
abdominal pain.17
Breakthroughs in diagnostic technology and the more frequent
and systematic use of existing tests could be particularly useful
in shortening the interval to referral for patients with these
cancers (table⇓). For example, diagnosis of multiple myeloma
might be improved by a point of care (finger prick) test currently
in early clinical application, which detects immunoglobulin free
light chains,18 or by greater use of existing blood tests, such as
those for inflammatory markers including plasma viscosity.19
For pancreatic cancer, tests that measure microRNA levels in
blood are being explored.20Another approach is tomake imaging
technologies, such as ultrasonography for abdominal complaints,
more accessible at the point of care.21 Novel diagnostic tests
will need careful evaluation, ideally in pragmatic randomised
controlled trials in primary care.
Easier to suspect cancers
These cancers (for example, breast, endometrial, or testicular
cancer) are of lower diagnostic difficulty because most patients
present with fairly specific signs and symptoms.
However, some patients experience multiple consultations for
reasons that are not entirely clear but are likely to include
atypical presentations, personal preference for delayed referral,
and suboptimal clinical reasoning or other healthcare factors.1
When patients who had multiple consultations are subsequently
diagnosed with easier to suspect cancers, quality improvement
approaches, such as significant event audits, should be triggered
to help understand the factors responsible and to identify
opportunities for improvement (table⇓).
Intermediate cancers
Some patients with cancers in the intermediate category of
diagnostic difficulty (such as colorectal and renal cancers) have
specific symptoms but others present atypically. The
interventions that could be helpful for this category of cancers
are potentially useful for all cancers. Decision support
interventions may be of particular value.22 Enabling access to
specialist expertise or investigations (such as imaging and
endoscopy) may also be particularly helpful, and can be
supported by case discussion arrangements with specialists. In
a national primary care audit, GPs judged that better access to
investigations would have altered management in 8-20% of
patients subsequently diagnosed with cancers for which
endoscopy or imaging are the principal diagnostic modalities,
such as abdominal organ cancers.6
Potential indirect benefits and harms
Incidental diagnosis of asymptomatic lesions of uncertain
prognosis may occur in symptomatic patients who have imaging
investigations for suspected cancer, with unclear patient
benefit.23 On the other hand, investigations in some patients
with suspected cancer will enable diagnosis of other diseases
that are causing the symptoms (for example, inflammatory bowel
disease diagnosed as a result of tests for suspected colorectal
cancer), and these patients will benefit from timely and accurate
diagnosis and treatment. A better understanding is needed of
the potential for indirect benefits and harms from tests for
symptomatic patients, bearing in mind that most patients express
a preference to be investigated for potential cancer at risk levels
as low as 1%,24 which is well below current detection rates of
about 10% among patients referred for suspected cancer.25
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Cancer policy and research
Efforts to reduce multiple consultations should not deflect
attention from opportunities to shorten diagnostic intervals that
may lie either with the patient before presentation or with
secondary care after referral. For example, the time from
symptom onset to first presentation is longer than a month for
a quarter of women later diagnosedwith breast cancer, compared
with an average interval to referral after presentation of zero
days.6 26 Avoidable delays after referral have been reported for
patients later diagnosed with colorectal cancer—in a US study
the median time from first referral to completion of colonoscopy
was 123 days,27 although relevant UK evidence is currently
sparse.
When cancer is suspected but symptoms are non-localising,
new models of multispecialty diagnostic services can help to
integrate diagnostic assessment processes and minimise
prolonged investigation intervals or the risk of referral to the
“wrong” specialty. Such services have been recently established
in Denmark and are being piloted in England through the
Accelerate Coordinate Evaluate (ACE) NHS initiative. Any
new interventions or diagnostic service models need to be
evaluated using rigorous study designs in primary care
populations.
Examining variation in measures of diagnostic activity (such
as use of endoscopy or imaging) across general practices might
provide insight into how to improve diagnostic quality.28 29
Improving the diagnostic process requires the development of
failsafe systems for overlooked abnormal tests and recall of
patients who did not attend planned investigations or follow-up
appointments.30 31
Substantial advances in surgical safety have been made by
considering the performance of theatre teams and hospital
systems in addition to the competency of individual surgeons.32
Similarly, research to improve diagnostic timeliness should
encompass system-wide factors, including communication
between primary and secondary care.
We argue that prolonged diagnostic intervals chiefly reflect
limitations in scientific knowledge and in the organisation and
delivery of healthcare. This understanding is critical for
informing the development of novel research strategies and
policies to improve diagnostic quality.We advocate a framework
for future research and improvement strategies that recognises
the central role of variation in diagnostic difficulty across
different cancers and organisational factors. We also advocate
better information for the public, the media, and policy makers
about the origins of prolonged intervals between presentation
and diagnosis of cancer.
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Key messages
Most patients who have cancer diagnosed after the onset of symptoms are referred after one or two GP consultations (80%), but a
substantial minority (20%) have three or more consultations
Multiple GP consultations prolong diagnostic intervals and may affect clinical outcomes and care experience
The proportion of patients who have multiple consultations varies by cancer site, consistent with variation in each cancer’s symptom
signature, with some cancers being harder to suspect than others
Diagnostic difficulty and the need for investigations in primary care could contribute substantially to the risk of multiple consultations
Diagnosis may be swifter if facilitated by decision support interventions, better interactions between generalists and specialists, and
easier access to diagnostics
Policy initiatives focusing solely on professional performance are unlikely to be effective
32 Vincent C, Moorthy K, Sarker SK, Chang A, Darzi AW. Systems approaches to surgical
quality and safety: from concept to measurement. Ann Surg 2004;239:475-82.
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Table
Table 1| How interventions to improve diagnostic timeliness might be applied to cancers in different diagnostic difficulty categories
Diagnostic support interventions*DefinitionCategory
Increased research investment in development of novel point of
care tests and greater use of existing tests
Most patients present with non-specific symptoms (eg,
multiple myeloma, pancreas, stomach, lung)
Harder to suspect
Better decision support during consultation integrated with
electronic health records. Wider access to diagnostic tests and
specialist advice
Some patients present with specific symptoms, but others
present atypically (eg, colon, renal, lymphoma)
Intermediate*
Quality improvement interventions, including significant event
audits and root cause analysis
Most patients present with highly specific symptoms or signs
(eg, breast, melanoma, endometrial, testicular, bladder)
Easier to suspect
*The association of interventions with diagnostic difficulty categories is not absolute—for example, patients with cancers of intermediate diagnostic difficulty can
also benefit from novel diagnostic tests.
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Figure
Percentage of patients with cancer who had three or more consultations with a general practitioner before referral. These
data can be used to categorise cancers as “easier to suspect” (melanoma, breast, endometrial cancer), “harder to suspect”
(multiple myeloma, pancreatic, ovarian, stomach, lung), or of intermediate diagnostic difficulty. Reprinted from Lyratzopoulos
G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital
referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol
2012;13:353-65 with permission from Elsevier.
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